Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review
Anastasia Levinta, Shakila Meshkat, Roger S. McIntyre, et al.
Journal of Affective Disorders (2022) Vol. 318, pp. 139-149
Closed Access | Times Cited: 18

Showing 18 citing articles:

Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
Cameron N. Calder, Angela T.H. Kwan, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 753-762
Closed Access | Times Cited: 8
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada
Carson Chrenek, Bryan Duong, Atul Khullar, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 7
Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention
Michał Walaszek, Zofia Kachlik, Wiesław Jerzy Cubała
Nutritional Neuroscience (2024), pp. 1-14
Closed Access | Times Cited: 6
The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
Jiafang Wang, Yankun Feng, Qi Zhong, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
Alina Wilkowska, Wiesław Jerzy Cubała
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14605-14605
Open Access | Times Cited: 13
Use of nitrous oxide in the treatment of major depressive disorder and treatment-resistant major depressive disorder: A systematic review and meta-analysis nitrous oxide in depressive disorders
Peterson Rech, Rodrigo Miranda Custodio, Maria Laura Rodrigues Uggioni, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 129, pp. 110869-110869
Closed Access | Times Cited: 6
Ketamine for Adults With Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update
Angela M. Barbara, Weiyi Xie, Quenby Mahood, et al.
Canadian Journal of Health Technologies (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report
L A Arrighi, Éloïse Maakaron, Théo Korchia, et al.
International Clinical Psychopharmacology (2023) Vol. 39, Iss. 5, pp. 323-325
Closed Access | Times Cited: 5
Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension
Sanne Y. Smith-Apeldoorn, Jolien K. E. Veraart, Jeanine Kamphuis, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 1
Nutritional Strategies in Major Depression Disorder: From Ketogenic Diet to Modulation of the Microbiota-Gut-Brain Axis
Ali Nikdasti, Elaheh Sadat Khodadadi, Felora Ferdosi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
Low-carbohydrate diet as a disease modifier for relapse prevention of treatment-resistant depression. Spotlight on neuroplasticity and brain-derived neurotrophic factor
Zofia Kachlik, Michał Walaszek, Wiesław Jerzy Cubała
Medical Hypotheses (2024) Vol. 187, pp. 111356-111356
Closed Access
Abnormal resting-state functional connectivity of the Right Anterior Cingulate Cortex in chronic ketamine users and its correlation with cognitive impairments
Jun Zhong, Fengchun Wu, Huawang Wu, et al.
Asian Journal of Psychiatry (2024) Vol. 102, pp. 104199-104199
Closed Access
Esketamine Nasal Spray: Rapid Relief for TRD and Suicide Prevention—Mechanisms and Pharmacodynamics
Hui Song, Yang Luo, Lingzhi Fang
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2059-2071
Open Access
An editorial view on restoring the balance of intestinal microbiota and its relevance to most of the neuropsychiatric disorders
Georgiana Oprea, Madalina Ghidersa, Ioana Miruna Balmus, et al.
Bulletin of Integrative Psychiatry (2023) Vol. 96, Iss. 1, pp. 35-38
Open Access


Bulletin of Integrative Psychiatry (2023) Vol. 96, Iss. 1
Open Access
New Frontiers in Ketamine Research: From Mechanisms of Action to Novel Psychiatric Treatment Approaches
Marcus C. Rosenhagen, Julien Elowe, Alberto Forte, et al.
American Journal of Psychiatry and Neuroscience (2023)
Open Access
Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension
Sanne Y. Smith-Apeldoorn, JKE Veraart, Jeanine Kamphuis, et al.
Research Square (Research Square) (2023)
Open Access
Ketamine and Nitrous Oxide
Alvin M. Janski, Vasilis Hristidis, Charles F. Zorumski, et al.
Elsevier eBooks (2023)
Closed Access
Page 1

Scroll to top